Jeffrey L. Wade

Jeffrey L. Wade

Former President and Chief Financial OfficeratLexicon Pharmaceuticals· In proxies 2021–2024

Pay in FY2023-1% from the year before · Lexicon Pharmaceuticals stock -19.9% the same year

Jeffrey L. Wade was paid $2.0M in FY2023 (Dec), down 1%. Lexicon Pharmaceuticals stock fell 19.9% that year.

Pay$100 in the stock at the end of FY20 → $45
Pay is from the Summary Compensation Table of each Lexicon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lexicon PharmaceuticalsPublic company · 5 yr
    • Former President and Chief Financial Officer2021 – Present · 5 yrStock in role -57%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?